Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Infocom And KNIME GmbH Jointly Develop Modules for Drug Development Technology

This article was originally published in PharmAsia News

Executive Summary

Tokyo-based Infocom Corp, a system developer for pharmaceutical research facilities, has signed a licensing agreement with the German firm KNIME GmbH for developing and marketing business computer processing modules based on KNIME, a work flow platform designed to assist drug development research. KNIME, developed by Konstanz University in Germany, is an open system platform which is customizable for different modules and systems. Additionally, Infocom's licensing agreements with Hungarian company ChemAxon and KNIME have allowed it to develop the cheminformatics program suite JChem Node Extension, expected to launch in February 2008. (Click here for more-Japanese language



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts